Related Experiment Videos
New human transforming genes detected by a tumorigenicity assay
Abstract:
We have developed a sensitive bioassay for transforming genes based on the tumorigenicity of cotransfected NIH3T3 cells in nude mice. The assay differs substantially from the NIH3T3 focus assay. Using it, we have detected the transfer of three transforming genes from the DNA of MCF-7, a human mammary carcinoma cell line. One of these is N-ras, which is amplified in MCF-7 DNA. The other two, which we have called mcf2 and mcf3, do not appear to be related to known oncogenes. We cannot detect their transfer by using the NIH3T3 focus assay. We do not yet know whether either mcf2 or mcf3 is associated with genetic abnormalities in MCF-7 cells.
Insights
Researchers identified three transforming genes in human breast cancer cells using a novel bioassay. This new method, based on cell tumorigenicity, detected N-ras and two previously unknown oncogenes, mcf2 and mcf3.
Area of Science:
- Molecular Biology
- Oncology
- Cancer Genetics
Background:
- Identifying transforming genes is crucial for understanding cancer development.
- Existing assays like the NIH3T3 focus assay have limitations in detecting certain oncogenes.
- The MCF-7 cell line, derived from human breast adenocarcinoma, is a common model for studying mammary carcinoma.
Purpose of the Study:
- To develop a sensitive bioassay for detecting transforming genes.
- To identify and characterize transforming genes present in the DNA of MCF-7 human mammary carcinoma cells.
- To compare the efficacy of the novel bioassay with the traditional NIH3T3 focus assay.
Main Methods:
- Development of a sensitive bioassay based on the tumorigenicity of cotransfected NIH3T3 cells in nude mice.
- Application of the bioassay to detect transforming gene transfer from MCF-7 cell DNA.
- Comparison of results with the standard NIH3T3 focus assay.
Main Results:
- The novel bioassay successfully detected the transfer of three transforming genes from MCF-7 DNA.
- One identified gene was N-ras, which is known to be amplified in MCF-7 DNA.
- Two novel transforming genes, designated mcf2 and mcf3, were identified and could not be detected by the NIH3T3 focus assay.
Conclusions:
- A sensitive bioassay for transforming genes has been established, offering advantages over existing methods.
- The MCF-7 cell line harbors at least three distinct transforming genes, including N-ras and two novel candidates (mcf2, mcf3).
- The newly identified genes mcf2 and mcf3 represent potential new targets for cancer research, as they are not detected by conventional assays.